Efeitos dos probióticos no perfil lipídico: revisão sistemática
Effects of probiotics on the lipid profile: systematic review
Carlos Jorge Maciel Uchoa Gadelha; Alane Nogueira Bezerra
Resumo
Palavras-chave
Abstract
Abstract: Alterations in the intestinal microbiota can modulate mechanisms involving risk factors for cardiovascular diseases, including dyslipidemias The objective was to review the effects of probiotic supplementation on the prevention and treatment of changes to the lipid profile. The searches were run on the PubMed database, using the descriptors “probiotics and lipid profile” and “probiotics and dyslipidemia,” with publication dates restricted to 2013 to 2018. Supplementation with probiotics significantly reduced total cholesterol, LDL-c, and triglycerides and increased HDL-c. Some benefits were observed on anthropometric variables, glycemic control, oxidative stress, inflammation, and immune system. The present study suggests that probiotic supplementation should be indicated as adjunctive treatment for dyslipidemias. Further studies should be developed to clarify long-term effects, as well as the influence of probiotics in combination with drug therapy.
Keywords
References
Fuster V. Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results. J Am Coll Cardiol. 2014;64(5):520-22. http://dx.doi.org/10.1016/j.jacc.2014.06.1151. PMid:25082587.
Luo L, Liu M. Adipose tissue in control of metabolism. J Endocrinol. 2016;231(3):R77-99. http://dx.doi.org/10.1530/JOE-16-0211. PMid:27935822.
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-52. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404. PMid:16157765.
Sherbet DP, Garg P, Brilakis ES, Banerjee S. Low-density lipoprotein cholesterol: how low can we go. Am J Cardiovasc Drugs. 2013;13(4):225-32. http://dx.doi.org/10.1007/s40256-013-0013-8. PMid:23609530.
Moran CP, Shanahan F. Gut microbiota and obesity: Role in aetiology potential therapeutic target. Best Pract Res Clin Gastroenterol. 2014;28(4):585-97. http://dx.doi.org/10.1016/j.bpg.2014.07.005. PMid:25194177.
Huttenhower C, Gevers D, Knight R, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-14. http://dx.doi.org/10.1038/nature11234. PMid:22699609.
Rebolledo C, Cuevas A, Zambrano T, et al. Bacterial community profile of the gut microbiota differs between hypercholesterolemic subjects and controls. BioMed Res Int. 2017;2017:8127814. http://dx.doi.org/10.1155/2017/8127814. PMid:28698878.
Firouzi S, Barakatun-Nisak MY, Ismail A, Majid HA, Nor Azmi K. Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies. Int J Food Sci Nutr. 2013;64(6):780-6. http://dx.doi.org/10.3109/09637486.2013.775227. PMid:23484591.
Lai H-C, Young JD, Lin C-S, et al. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease. Biomed J. 2014;37(5):259-68. http://dx.doi.org/10.4103/2319-4170.138314. PMid:25179725.
Coppola MM, Gil-Turnes C. Probióticos e resposta imune. Cienc Rural. 2004;34(4):1297-303. http://dx.doi.org/10.1590/S0103-84782004000400056.
Ooi LG, Liong MT. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci. 2010;11(6):2499-522. http://dx.doi.org/10.3390/ijms11062499. PMid:20640165.
Ahn HY, Kim M, Chae JS, et al. Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein AV levels in non-diabetic subjects with hypertriglyceridemia. Atherosclerosis. 2015;241(2):649-56. http://dx.doi.org/10.1016/j.atherosclerosis.2015.06.030. PMid:26117402.
Bernini LJ, Simão ANC, Alfieri DF, et al. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: a randomized trial. Effects of probiotics on metabolic syndrome. Nutrition. 2016;32(6):716-9. http://dx.doi.org/10.1016/j.nut.2015.11.001. PMid:27126957.
Cavallini DC, Manzoni MS, Bedani R, et al. Probiotic soy product supplemented with isoflavones improves the lipid profile of moderately hypercholesterolemic Men: a randomized controlled trial. Nutrients. 2016;8(1):52. http://dx.doi.org/10.3390/nu8010052. PMid:26797632.
Childs CE, Röytiö H, Alhoniemi E, et al. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. Br J Nutr. 2014;111(11):1945-56. http://dx.doi.org/10.1017/S0007114513004261. PMid:24661576.
Dong H, Rowland I, Thomas LV, Yaqoob P. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Nutr. 2013;52(8):1853-63. http://dx.doi.org/10.1007/s00394-012-0487-1. PMid:23307112.
Dönmez N, Kısadere İ, Balaban C, Kadiralieva N. Effects of traditional homemade koumiss on some hematological and biochemical characteristics in sedentary men exposed to exercise. Biotech Histochem. 2014;89(8):558-63. http://dx.doi.org/10.3109/10520295.2014.915428. PMid:24893332.
Fuentes MC, Lajo T, Carrión JM, Cuñé J. Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. Br J Nutr. 2013;109(10):1866-72. http://dx.doi.org/10.1017/S000711451200373X. PMid:23017585.
Gomes AC, Sousa RGM, Botelho PB, Gomes TLN, Prada PO, Mota JF. The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: a double‐blind, randomized trial. Obesity (Silver Spring). 2017;25(1):30-8. http://dx.doi.org/10.1002/oby.21671. PMid:28008750.
Ivey KL, Hodgson JM, Kerr DA, Thompson PL, Stojceski B, Prince RL. The effect of yoghurt and its probiotics on blood pressure and serum lipid profile: a randomised controlled trial. Nutr Metab Cardiovasc Dis. 2015;25(1):46-51. http://dx.doi.org/10.1016/j.numecd.2014.07.012. PMid:25171898.
Kullisaar T, Zilmer K, Salum T, Rehema A, Zilmer M. The use of probiotic L. fermentum ME-3 containing Reg’Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study. Nutr J. 2016;15(1):93. http://dx.doi.org/10.1186/s12937-016-0213-6. PMid:27793203.
Ogawa A, Kadooka Y, Kato K, Shirouchi B, Sato M. Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects. Lipids Health Dis. 2014;13(1):36. http://dx.doi.org/10.1186/1476-511X-13-36. PMid:24548293.
Rajkumar H, Mahmood N, Kumar M, Varikuti SR, Challa HR, Myakala SP. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial. Mediators Inflamm. 2014;2014:348959. http://dx.doi.org/10.1155/2014/348959. PMid:24795503.
Ryan JJ, Hanes DA, Schafer MB, Mikolai J, Zwickey H. Effect of the probiotic Saccharomyces boulardii on cholesterol and lipoprotein particles in hypercholesterolemic adults: a single-arm, open-label pilot study. J Altern Complement Med. 2015;21(5):288-93. http://dx.doi.org/10.1089/acm.2014.0063. PMid:25893960.
Tonucci LB, Santos KMO, de Oliveira LL, Ribeiro SMR, Martino HSD. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr. 2017;36(1):85-92. http://dx.doi.org/10.1016/j.clnu.2015.11.011. PMid:26732026.
Guo Z, Liu XM, Zhang QX, et al. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2011;21(11):844-50. http://dx.doi.org/10.1016/j.numecd.2011.04.008. PMid:21930366.
Wang L, Guo MJ, Gao Q, et al. The effects of probiotics on total cholesterol: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97(5):e9679. http://dx.doi.org/10.1097/MD.0000000000009679. PMid:29384846.
Mello AP, da Silva IT, Abdalla DSP, Damasceno NRT. Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis. 2011;215(2):257-65. http://dx.doi.org/10.1016/j.atherosclerosis.2010.12.028. PMid:21292266.
Kim JY, Park JH, Jeong SW, et al. High levels of remnant lipoprotein cholesterol is a risk factor for large artery atherosclerotic stroke. J Clin Neurol. 2011;7(4):203-9. http://dx.doi.org/10.3988/jcn.2011.7.4.203. PMid:22259616.
Gordon B, Chen S, Durstine JL. The effects of exercise training on the traditional lipid profile and beyond. Curr Sports Med Rep. 2014;13(4):253-9. http://dx.doi.org/10.1249/JSR.0000000000000073. PMid:25014391.
Pitsavos C, Tampourlou M, Panagiotakos DB, et al. Association between low-grade systemic inflammation and type 2 diabetes mellitus among men and women from the ATTICA study. Rev Diabet Stud. 2007;4(2):98-104. http://dx.doi.org/10.1900/RDS.2007.4.98. PMid:17823694.
Bezerra AN, Carvalho NS, Viana ACC, Morais SR. Efeito da suplementação de probióticos no diabetes mellitus: uma revisão sistemática. Revista HUPE. 2017;15(2):129-39.
Chen G, Wang H, Zhang X, Yang ST. Nutraceuticals and functional foods in the management of hyperlipidemia. Crit Rev Food Sci Nutr. 2014;54(9):1180-201. http://dx.doi.org/10.1080/10408398.2011.629354. PMid:24499150.
Soccol CR, de Souza Vandenberghe LP, Spier MR, et al. The potential of probiotics: a review. Food Technol Biotechnol. 2010;48(4):413-34.
Miglioranza B, Miglioranza LHDS, Henrique FC, et al. The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks. Expert Opin Ther Targets. 2015;19(8):1127-38. http://dx.doi.org/10.1517/14728222.2015.1028361. PMid:25872805.
Begley M, Hill C, Gahan CGM. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol. 2006;72(3):1729-38. http://dx.doi.org/10.1128/AEM.72.3.1729-1738.2006. PMid:16517616.
Edwards JE, Moore RA. Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Fam Pract. 2003;4(1):18. http://dx.doi.org/10.1186/1471-2296-4-18. PMid:14969594.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email